SCHEMBL28404693

SCHEMBL28404693

NC(=O)OCC(C(=O)Nc1cc2ccncc2s1)c1ccc(OCC(O)CO)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 18/20 0.40
ROCK1 Q13464 2/20 0.38
MYLK4 Q86YV6 1/20 0.38
CYP1A2 P05177 1/20 0.38
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36
ABL1 P00519 1/20 0.36
RET P07949 1/20 0.36
PIM1 P11309 1/20 0.36
FGFR1 P11362 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36
GRK5 P34947 1/20 0.36
KDR P35968 1/20 0.36
MAPK8 P45983 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30744170 0.91 ROCK2 (0.49) ROCK2ROCK1MYLK4
SCHEMBL23501244 0.91 ROCK2 (0.49) ROCK2ROCK1MYLK4
SCHEMBL23501376 0.88 ROCK2 (0.37) ROCK2ROCK1MYLK4PIM1
SCHEMBL23501373 0.86 ROCK2 (0.38) ROCK2ROCK1MYLK4
SCHEMBL28401817 0.85 ROCK2 (0.50) ROCK2ROCK1MYLK4CHEK1AURKA
SCHEMBL28577772 0.85 ROCK2 (0.50) ROCK2ROCK1MYLK4CHEK1AURKA
SCHEMBL28405939 0.85 ROCK2 (0.48) ROCK2ROCK1MYLK4CHEK1AURKA
SCHEMBL23927580 0.83 ROCK2 (0.34) ROCK2ROCK1MYLK4
SCHEMBL23522316 0.83 ROCK2 (0.37) ROCK2ROCK1MYLK4DYRK1A
SCHEMBL23927576 0.81 ROCK2 (0.36) ROCK2ROCK1MYLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111217834-B Nitroxide derivatives of ROCK kinase inhibitors 维眸生物科技(上海)有限公司 2021-10-26 CN disclosed
CN-111217834-A Nitroxide derivatives of ROCK kinase inhibitors 维眸生物科技(上海)有限公司 2020-06-02 CN disclosed